Patents Assigned to GLSynthesis, Inc.
  • Patent number: 8796292
    Abstract: The invention features compounds of formula (I): The compounds are useful as antibacterial agents, especially again Clostridium difficile-associated diseases.
    Type: Grant
    Filed: September 10, 2010
    Date of Patent: August 5, 2014
    Assignee: GLSynthesis Inc.
    Inventors: George E. Wright, Wei-Chu Xu
  • Patent number: 8575127
    Abstract: The invention features compounds of formula I and methods of their use as antiplatelet and antithrombotic compounds: H/N=Q?2OOOO?Q2-N, HR6/NIf)(^XMO-M??OM°?X1MQ?)r(^rfHOOHHOOQHiN?iR2 Formula (I).
    Type: Grant
    Filed: November 20, 2009
    Date of Patent: November 5, 2013
    Assignee: GLSynthesis Inc.
    Inventors: Ivan Borissov Yanachkov, George Edward Wright
  • Patent number: 8288545
    Abstract: This invention features bis-amides of pyrophosphoric acid and bisphosphonic acids, their preparation, and their use in synthesis of P1,P4-dinucleoside tetraphosphates, tetraphosphonates, and related compounds.
    Type: Grant
    Filed: July 23, 2007
    Date of Patent: October 16, 2012
    Assignee: GLSynthesis Inc.
    Inventors: Ivan Yanachkov, George E. Wright
  • Publication number: 20110257252
    Abstract: The invention features compounds of formula I and methods of their use as antiplatelet and antithrombotic compounds: H/N=Q?2OOOO?Q2-N, HR6/NIf)(?XMO-M??OM°?X1MQ?)r(?rfHOOHHOOQHiN?iR2 Formula (I).
    Type: Application
    Filed: November 20, 2009
    Publication date: October 20, 2011
    Applicant: GLSynthesis Inc.
    Inventors: Ivan Borisso Yanachkov, George Edward Wright
  • Publication number: 20090299048
    Abstract: This invention features bis-amides of pyrophosphoric acid and bisphosphonic acids, their preparation, and their use in synthesis of P1,P4-dinucleoside tetraphosphates, tetraphosphonates, and related compounds.
    Type: Application
    Filed: July 23, 2007
    Publication date: December 3, 2009
    Applicant: GLSynthesis Inc
    Inventors: Ivan Yanachkov, George E. Wright
  • Patent number: 6926763
    Abstract: The invention features compounds of the formula: or a pharmaceutically acceptable salt thereof, wherein A is CR2 and B is N; wherein n is 0-3; wherein R1 is (CH2)m—{(G)o—(CH2)p}q—L, in which G is CH2, CH?CH, C?C, CO, O, S, or NR5, where R5 is H or C1-6 alkyl, CHR6, where R6 is OH or C1-6 alkyl, CH(CR7R8), where each of R7 and R8 is, independently, H, halo, or C1-6 alkyl, OCO, CONR9, NR10CO, where each of R9 and R10 is, independently, H or C1-6 alkyl, SO2NH, or NHSO2; in which m is 1-4, o is 0-4, p is 0-4, and q is 0-4. The compounds disclosed herein have potent anti-microbial, e.g., both Gram-positive and Gram-negative anti-bacterial properties. The compounds inhibit DNA polymerase IIIC and DNA polymerase IIIE enzymes and thus act therapeutically by inhibiting the growth of a broad array of bacteria. The compounds can be administered to prevent or to treat Gram-positive or Gram-negative bacterial infections, e.g., in eukaryotic cell cultures, animals, or humans.
    Type: Grant
    Filed: February 10, 2003
    Date of Patent: August 9, 2005
    Assignee: GLSynthesis, Inc.
    Inventors: George E. Wright, Wei-Chu Xu, Neal C. Brown